In the News

Share
1661 News Items found
MSK patient Guillaume Arnould  high fives with his son.
Treating Relapsed Multiple Myeloma With CAR T Cell Therapy Targeting GPRC5D
Learn how CAR T cell therapy and the expertise of MSK gave Guillaume Arnould another option for treating multiple myeloma, after other therapies failed.
Group of Black men posing at prostate cancer fundraising walk.
Annual Prostate Cancer Screening Pays Off for Black Community Leader in Harlem
A Black community leader seeks prompt treatment for prostate cancer, avoiding the harsh toll the disease often takes on men like him.
Breast cancer patient Natasha Bhalla meditates.
Helping People With Cancer Afford Food and Crucial Technology
Learn how MSK helps cancer patients in underserved communities with technology, food, language interpretation, and more. Natasha Bhalla, an MSK patient with breast cancer, talks about the difference it's made for her.
Detail of an MSK scientist working in a lab
MSK Research Highlights, October 31, 2023
New MSK research identifies a promising immunotherapy target for acute myeloid leukemia; decodes genetic differences in tumors from patients with African ancestry; and finds a virtual mind-body fitness program reduced hospitalizations for those in active cancer treatment. A clinical trial led by MSK also resulted in the approval of a new combination therapy for non-small cell lung cancer.
Memorial Sloan Kettering Ralph Lauren Center nurse Jasmine Gibson, breast cancer patient Maria Tucker, and nurse Margaret Bediones
Expert Breast Cancer Treatment in Harlem at MSK’s Ralph Lauren Center
See how experts at Memorial Sloan Kettering Cancer Center's Ralph Lauren Center cared for Maria close to home.
Article
A research working in an MSK lab
MSK Research Highlights, October 19, 2023
New MSK research examines how diabetes may speed the growth of multiple myeloma; analyzes the increasing number of patients who are benefiting from precision oncology; and highlights the unexpected role of the integrated stress response in response to genomic instability in mitochondrial DNA.
Mijin Kim seen working in laboratory.
Advice From a ‘Wunderkind’: Why MSK Is Great for Early Career Researchers
Learn why post-doctoral researcher Mijin Kim believes Memorial Sloan Kettering is an excellent choice for early career biomedical researchers, as she enjoys her recognition as a STAT Wunderkind, class of 2023.
Feature
Joanna Ihlo
Fighting Cancer on a Fixed Income: How MSK Helps Patients Cope With Financial Uncertainty
Learn how MSK helps patients navigate the intricacies of insurance and financial assistance throughout their cancer treatment.
Finding
Dr. Zsofia Stadler
Preventing Lynch Syndrome Cancers: New Study Suggests Immunotherapy Could Work
An analysis of patients with Lynch syndrome treated at MSK finds that immunotherapy drugs called checkpoint inhibitors may prevent serious tumors from forming.
MSK physician Dr. Deb Schrag
Experimental Blood Test for Cancer Shows Potential To Screen for Multiple Types Simultaneously
Learn how a blood test could someday provide a way to detect cancers at an early stage.